Calculus Capital is a pioneer of tax efficient investing, having launched the UK’s first approved EIS Fund in 1999. We offer an opportunity to invest in a portfolio of entrepreneurial UK growth businesses, through our award winning Calculus EIS Funds and Calculus VCT. We invest in the fastest growing sectors of the UK economy – technology, healthcare and creative industries.
Learn about the tax-efficient investment opportunities offered by our Calculus EIS Fund and Calculus VCT (0% Initial Fee Until 05 April)
We would be delighted to learn about your business and discuss whether Calculus could be a suitable investment partner
The initial administration of Arecor’s insulin candidate to a patient marks a significant step forward in the quest to transform the management of type 2 diabetes. Arecor’s innovative therapy has the potential to revolutionise the way this disease is treated, offering new hope and improved outcomes for individuals living with diabetes.
Calculus EIS, VCT and Creative Content EIS portfolio company Brouhaha screened their new feature film Firebrand ahead of its release and entry at upcoming film festivals. Firebrand stars Jude Law, Alicia Vikander and Simon Russell Beale and is directed by Karim Aïnouz, the film tells the story of Henry VIII’s sixth and last wife, Catherine … Continued
CEO, John Glencross quoted in this article regarding the potential removal of the sunset clause.
Modi-1 cancer vaccine showed partial response and stable disease in patients with hard-to-treat head and neck, high grade serous ovarian or triple negative breast cancers.
